株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

下腿潰瘍:世界の治験レビュー

Leg Ulcers Global Clinical Trials Review, H2, 2017

発行 GlobalData 商品コード 240559
出版日 ページ情報 英文 110 Pages
即納可能
価格
本日の銀行送金レート: 1USD=110.58円で換算しております。
Back to Top
下腿潰瘍:世界の治験レビュー Leg Ulcers Global Clinical Trials Review, H2, 2017
出版日: 2017年11月22日 ページ情報: 英文 110 Pages
概要

当レポートでは、下腿潰瘍治療薬に関する治験動向について、治験数および被験者数、段階別・相別の状況、有望企業、開発中の治療薬の情報などをまとめ、概略以下の構成でお届けします。

イントロダクション

地域別の治験動向

  • 国別の治験動向
    • アジア太平洋地域の主要5ヶ国
    • 欧州の主要5ヶ国
    • 北米の主要国
    • 中東・アフリカの主要国
    • 中南米の主要国

G7諸国における治験

G7諸国における治験:治験状況別

相別の治験状況

現在進行中の治験

一定期間に採用された被験者

有望なスポンサー

  • 下腿潰瘍治療薬の治験に参加している主要企業

有望な治療薬の比較

治験プロファイル

  • 主要企業の治験概要
    • Smith & Nephew Plc
    • Tissue Therapies Limited
    • Shire Plc
    • NB Therapeutics, Inc.
    • Johnson & Johnson
    • CytoTools AG
    • CoDa Therapeutics, Inc.
    • AUS Bio Limited
    • Altrika Ltd
    • Air Liquide S.A.
  • 主要大学/研究所/病院の治験概要
    • Department of Health, South Africa
    • Department of Health, UK
    • University of Leipzig
    • Assistance Publique - Hopitaux de Paris
    • University of Pennsylvania
    • Medical University of South Carolina
    • Southwest Regional Wound Care Center
    • University of York
    • UMC Utrecht Holding BV
    • Queen's University

図表

目次
Product Code: GDHC4702CTIDB

GlobalData's clinical trial report, "Leg Ulcers Global Clinical Trials Review, H2, 2017" provides an overview of Leg Ulcers clinical trials scenario. This report provides top line data relating to the clinical trials on Leg Ulcers. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table of Contents

Table of Contents

Table of Contents 2

  • List of Tables 3
  • List of Figures 3
  • Report Guidance 4
  • GlobalData Clinical Trials Report Coverage 5
  • Clinical Trials by Region 6
  • Clinical Trials and Average Enrollment by Country 7
  • Top Five Countries Contributing to Clinical Trials in Asia-Pacific 9
  • Top Five Countries Contributing to Clinical Trials in Europe 10
  • Top Countries Contributing to Clinical Trials in North America 11
  • Top Countries Contributing to Clinical Trials in Middle East and Africa 12
  • Top Countries Contributing to Clinical Trials in Central and South America 13
  • Clinical Trials by G7 Countries: Proportion of Leg Ulcers to Dermatology Clinical Trials 14
  • Clinical Trials by Phase in G7 Countries 15
  • Clinical Trials in G7 Countries by Trial Status 16
  • Clinical Trials by E7 Countries: Proportion of Leg Ulcers to Dermatology Clinical Trials 17
  • Clinical Trials by Phase in E7 Countries 18
  • Clinical Trials in E7 Countries by Trial Status 19
  • Clinical Trials by Phase 20
  • In Progress Trials by Phase 21
  • Clinical Trials by Trial Status 22
  • Clinical Trials by End Point Status 23
  • Subjects Recruited Over a Period of Time 24
  • Clinical Trials by Sponsor Type 25
  • Prominent Sponsors 26
  • Top Companies Participating in Leg Ulcers Therapeutics Clinical Trials 27
  • Prominent Drugs 28
  • Clinical Trial Profile Snapshots 29

Appendix 108

  • Abbreviations 108
  • Definitions 108
  • Research Methodology 109
  • Secondary Research 109
  • About GlobalData 110
  • Contact Us 110
  • Source 110

List of Tables

List of Tables

  • Leg Ulcers Therapeutics, Global, Clinical Trials by Region, 2017* 6
  • Leg Ulcers Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 7
  • Leg Ulcers Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 8
  • Leg Ulcers Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2017* 9
  • Leg Ulcers Therapeutics Clinical Trials, Europe, Top Five Countries, 2017* 10
  • Leg Ulcers Therapeutics Clinical Trials, North America, Top Countries, 2017* 11
  • Leg Ulcers Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2017* 12
  • Leg Ulcers Therapeutics Clinical Trials, Central and South America, Top Countries, 2017* 13
  • Proportion of Leg Ulcers to Dermatology Clinical Trials, G7 Countries (%), 2017* 14
  • Leg Ulcers Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 15
  • Leg Ulcers Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 16
  • Proportion of Leg Ulcers to Dermatology Clinical Trials, E7 Countries (%), 2017* 17
  • Leg Ulcers Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 18
  • Leg Ulcers Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 19
  • Leg Ulcers Therapeutics, Global, Clinical Trials by Phase, 2017* 20
  • Leg Ulcers Therapeutics, Global, Clinical Trials In Progress by Phase 2017* 21
  • Leg Ulcers Therapeutics, Global, Clinical Trials by Trial Status, 2017* 22
  • Leg Ulcers Therapeutics Clinical Trials, Global, by End Point Status, 2017* 23
  • Leg Ulcers Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 24
  • Leg Ulcers Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2017* 25
  • Leg Ulcers Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 26
  • Leg Ulcers Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 27
  • Leg Ulcers Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 28

List of Figures

List of Figures

  • Leg Ulcers Therapeutics, Global, Clinical Trials by Region (%), 2017* 6
  • Leg Ulcers Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 7
  • Leg Ulcers Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 8
  • Leg Ulcers Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2017* 9
  • Leg Ulcers Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2017* 10
  • Leg Ulcers Therapeutics Clinical Trials, North America, Top Countries (%), 2017* 11
  • Leg Ulcers Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2017* 12
  • Leg Ulcers Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2017* 13
  • Proportion of Leg Ulcers to Dermatology Clinical Trials, G7 Countries (%), 2017* 14
  • Leg Ulcers Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 15
  • Leg Ulcers Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 16
  • Proportion of Leg Ulcers to Dermatology Clinical Trials, E7 Countries (%), 2017* 17
  • Leg Ulcers Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 18
  • Leg Ulcers Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 19
  • Leg Ulcers Therapeutics, Global, Clinical Trials by Phase (%), 2017* 20
  • Leg Ulcers Therapeutics, Global, Clinical Trials In Progress by Phase, 2017* 21
  • Leg Ulcers Therapeutics, Global, Clinical Trials by Trial Status, 2017* 22
  • Leg Ulcers Therapeutics Clinical Trials, Global, by End Point Status, 2017* 23
  • Leg Ulcers Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 24
  • Leg Ulcers Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2017* 25
  • Leg Ulcers Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 26
  • Leg Ulcers Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 27
  • Leg Ulcers Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 28
  • GlobalData Methodology 109
Back to Top